SPRC and NTLX Related Headlines
Go Back- SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
- SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
- Clearmind Medicine files Hong Kong patent for depression therapy combo
- Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
SPRC and NTLX Related Press Releases
Go Back- SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
- SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
- Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
